Funding supports Sorrento's staph infection work

Sorrento Therapeutics a two-year, $600,000 grant from the National Institute of Allergy and Infectious Diseases to support the company's develoment of antibody therapeutics and vaccines for Staph infections. The grant will help fund Phase I studies and could eventually lead to funding for Phase II trials. Article